Figure 4
From: 89Zr-panitumumab PET imaging for preoperative assessment of ameloblastoma in a PDX model
Ameloblastoma tumor tissue was confirmed in xenografts after resection by pathologic assessment (NB = non-blocking group; B = blocking group). Resected tumors, 7–9 weeks post implantation, were processed, embedded in paraffin and stained with hematoxylin and eosin (H&E, first column) or anti-EGFR for immunohistochemistry (second column) (20×). Negative controls (third column) show staining without primary antibody.
